AstraZeneca (LSE:AZN)
AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
{{ formattedPrice }} {{ change }} (0.91%)
Quotes delayed. Last trade: 25-05-2018, 04:51:07pm BST
| Open Price | {{ openPrice }} | Close Price | {{ closePrice }} |
| Day High | {{ high }} | Day Low | {{ low }} |
| Bid | {{ bid }} | Ask | {{ ask }} |
| Volume | 1901729 |
Related Articles
-
Is the AstraZeneca share price a FTSE 100 bargain or value trap?
Does AstraZeneca plc (LON:AZN) offer higher total return potential than the FTSE 100 (INDEXFTSE: UKX)? Read More »
-
One FTSE 100 6% dividend stock I’d buy with AstraZeneca
Roland Head explains why FTSE 100 (INDEXFTSE:UKX) pharma giant AstraZeneca plc (LON:AZN) is on his buy list. Read More »
-
Can you afford to miss out on Legal & General’s FTSE 100-walloping dividend yield?
With its 5.7% dividend yield comfortably ahead of the FTSE 100's (INDEXFTSE: UKX) average payout, is Legal & General Group plc (LON: LGEN) a... Read More »
-
Why I’d sell this FTSE 100 dividend stock to buy AstraZeneca
I am looking at a FTSE 100 (INDEXFTSE: UKX) share I would happily overlook for AstraZeneca plc (LON: AZN). Read More »
-
AstraZeneca and this small growth pharma stock could make you brilliantly rich
Harvey Jones finds a racy little pharma stock to sit beside dividend and growth monster AstraZeneca plc (LON: AZN) in your portfolio. Read More »
-
Should you follow Neil Woodford and sell AstraZeneca plc?
Neil Woodford has sold down his holding in AstraZeneca plc (LON: AZN). Should you copy him? Read More »
-
Are these the best FTSE 100 stocks to buy for your ISA?
These two FTSE 100 (INDEXFTSE: UKX) sector leaders have lots going for them to make them great ISA picks. Read More »
-
2 top value shares I’d buy right now
These two stocks appear to offer a mix of growth potential and sensible valuations. Read More »
-
Is now the time to buy this battered Footsie pharma stock?
Royston Wild looks at a troubled FTSE 100 (INDEXFTSE: UKX) stock and asks: could a share price turnaround be just around the corner? Read More »
-
AstraZeneca plc isn’t the only dividend stock I’d hold for the next decade
Roland Head explains why AstraZeneca plc (LON:AZN) could be a smart long-term buy. Read More »
